Zurich Cantonal Bank
LUMO

Zurich Cantonal Bank’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Zurich Cantonal Bank’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-59
Closed -$4K – 2548
2018
Q1 		$4K Sell
59
-1,082
-95% -$76.7K ﹤0.01% 2530
2017
Q4 		$83K Hold
1,141
– – ﹤0.01% 1693
2017
Q3 		$105K Buy
1,141
+1,082
+1,834% +$83K ﹤0.01% 1367
2017
Q2 		$4K Sell
59
-1,338
-96% -$166K ﹤0.01% 2509
2017
Q1 		$303K Sell
1,397
-41
-3% -$5.86K ﹤0.01% 914
2016
Q4 		$133K Sell
1,438
-16,819
-92% -$1.9M ﹤0.01% 1137
2016
Q3 		$2.47M Buy
18,257
+131
+0.7% +$13K 0.03% 569
2016
Q2 		$1.84M Buy
18,126
+551
+3% +$68.3K 0.02% 552
2016
Q1 		$2.88M Buy
17,575
+5,819
+49% +$1.18M 0.04% 442
2015
Q4 		$3.85M Buy
11,756
+552
+5% +$180K 0.05% 376
2015
Q3 		$3.61M Buy
11,204
+10,165
+978% +$4.47M 0.05% 361
2015
Q2 		$414K Buy
1,039
+328
+46% +$139K 0.01% 872
2015
Q1 		$350K Buy
+711
New +$276K ﹤0.01% 872

Other funds holding LUMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Zurich Cantonal Bank's LUMO Position: Q2 2018 in Review

Zurich Cantonal Bank sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q2 2018, closing a stake of 59 shares — an estimated $4K sold.

Zurich Cantonal Bank first reported a position in LUMO in Q1 2015 and held it in 13 quarters. The position peaked at $3.85M in Q4 2015. 106 funds tracked by Wall St. Rank hold LUMO as of Q2 2018.

  • Zurich Cantonal Bank reported no remaining Lumos Pharma, Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
  • Zurich Cantonal Bank sold 59 Lumos Pharma, Inc. Common Stock shares in Q2 2018, an estimated $4K.
  • Zurich Cantonal Bank first reported a position in Lumos Pharma, Inc. Common Stock in Q1 2015 and held it in 13 quarters.
  • Zurich Cantonal Bank's Lumos Pharma, Inc. Common Stock position peaked at $3.85M in Q4 2015.
  • 106 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q2 2018.

Based on Zurich Cantonal Bank's 13F filing for Q2 2018, filed 6 Aug 2018.